Gain-of-function of P2X7 receptor gene variants in multiple sclerosis

被引:62
|
作者
Oyanguren-Desez, Olatz [1 ,2 ,3 ]
Rodriguez-Antigueedad, Alfredo [4 ]
Villoslada, Pablo [5 ]
Domercq, Maria [1 ,2 ]
Alberdi, Elena [1 ,2 ,3 ]
Matute, Carlos [1 ,2 ,3 ]
机构
[1] Univ Basque Country, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Leioa 48940, Spain
[2] Univ Basque Country, Dept Neurociencias, Leioa 48940, Spain
[3] Neurotek, Zamudio, Spain
[4] Hosp Basurto, Serv Neurol, Bilbao, Spain
[5] Hosp Clin Barcelona, Barcelona, Spain
关键词
P2X7; receptors; Gene polymorphisms; Calcium permeability; Electrophysiology; Dye uptake; Multiple sclerosis; P2X(7) RECEPTOR; EXPRESSION; GLUTAMATE; OLIGODENDROCYTES; INHIBITION;
D O I
10.1016/j.ceca.2011.08.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously shown that P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates chronic experimental autoimmune encephalomyelitis. Here, we have explored the putative association of functionally relevant single nucleotide polymorphisms of the P2X7 receptor gene with multiple sclerosis. We found that T allele of rs17525809 polymorphism, which yields an Ala-76 to Val change in the extracellular domain, is more frequent in multiple sclerosis patients than in controls. Importantly, P2X7 variants with Val show a gain-of-function consisting in higher calcium permeability, larger electrophysiological responses and higher ethidium uptake, and enhance the effect of the also gain-of-function His-155 to Tyr substitution (rs208294) in the haplotype formed by these two variants. These findings may contribute to define the genetic background predisposing for multiple sclerosis and its pathophysiology. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 50 条
  • [1] Gain-of-function polymorphisms in the P2X7 purinergic receptor are associated with increased bone mass
    Husted, L. B.
    Gonzalez-Bofill, N.
    Carstens, M.
    Stenkjaer, L.
    Langdahl, B. L.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S99 - S100
  • [2] Vitamin D modulation on P2X7 receptor in Multiple Sclerosis
    Voo, V. T. F.
    O'Brien, T.
    Butzkueven, H.
    Monif, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (03) : NP33 - NP34
  • [3] Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
    Amadio, Susanna
    Parisi, Chiara
    Piras, Eleonora
    Fabbrizio, Paola
    Apolloni, Savina
    Montilli, Cinzia
    Luchetti, Sabina
    Ruggieri, Serena
    Gasperini, Claudio
    Laghi-Pasini, Franco
    Battistini, Luca
    Volonte, Cinzia
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [4] Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7
    Adriouch, Sahil
    Scheuplein, Felix
    Baehring, Robert
    Seman, Michel
    Boyer, Olivier
    Koch-Nolte, Friedrich
    Haag, Friedrich
    PURINERGIC SIGNALLING, 2009, 5 (02) : 151 - 161
  • [5] Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7
    Sahil Adriouch
    Felix Scheuplein
    Robert Bähring
    Michel Seman
    Olivier Boyer
    Friedrich Koch-Nolte
    Friedrich Haag
    Purinergic Signalling, 2009, 5 : 151 - 161
  • [6] Variants of the pro-inflammatory P2X7 receptor on platelets are associated with the acute attack of multiple sclerosis
    Gu, B.
    Krupa, M.
    Ou, A.
    Slee, M.
    Wiley, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 912 - 912
  • [7] P2X7 receptor variants influence pain
    Katherine Whalley
    Nature Reviews Neuroscience, 2012, 13 (5) : 289 - 289
  • [8] Elevated circulating microparticle counts in multiple sclerosis are regulated by platelet P2X7 receptor function
    Wiley, James
    Wong, Joelyn
    Krupa, Malgorzata
    Zhang, Vicky
    Gu, Ben
    Slee, Mark
    Teoh, Jian
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP19 - NP19
  • [9] P2X7 receptor and macrophage function
    Wewers, Mark D.
    Sarkar, Anasuya
    PURINERGIC SIGNALLING, 2009, 5 (02) : 189 - 195
  • [10] P2X7 receptor and macrophage function
    Mark D. Wewers
    Anasuya Sarkar
    Purinergic Signalling, 2009, 5 : 189 - 195